RU2004120868A - METHOD FOR DETERMINING ACTIVITY OF PATHOLOGICAL PROCESS BY ASTAHOVA - Google Patents

METHOD FOR DETERMINING ACTIVITY OF PATHOLOGICAL PROCESS BY ASTAHOVA Download PDF

Info

Publication number
RU2004120868A
RU2004120868A RU2004120868/15A RU2004120868A RU2004120868A RU 2004120868 A RU2004120868 A RU 2004120868A RU 2004120868/15 A RU2004120868/15 A RU 2004120868/15A RU 2004120868 A RU2004120868 A RU 2004120868A RU 2004120868 A RU2004120868 A RU 2004120868A
Authority
RU
Russia
Prior art keywords
forms
atypical
pathological process
cells
activity
Prior art date
Application number
RU2004120868/15A
Other languages
Russian (ru)
Inventor
Вера Семеновна Астахова (UA)
Вера Семеновна Астахова
Original Assignee
Вера Семеновна Астахова (UA)
Вера Семеновна Астахова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вера Семеновна Астахова (UA), Вера Семеновна Астахова filed Critical Вера Семеновна Астахова (UA)
Publication of RU2004120868A publication Critical patent/RU2004120868A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Claims (1)

Способ определения активности патологического процесса в организме человека путем использования клеточных показателей периферической крови, подсчета и дифференцирования разных форм клеток по стандартной методике, наибольшее 200 клеток в каждом из образцов, и определения процентного содержания отдельных форм клеток соответственно к заданным диапазонам, отличающийся тем, что используют нативные препараты лимфоцитарной фракции периферической крови, выделенные на градиенте фикол-урографина, подсчитывают процентное содержание атипичных эритроцитов и проводят качественную оценку количественных показателей активности патологического состояния из расчета: содержание атипичных форм эритроцитов от 6 до 20% указывает на локальный участок патологического процесса в неактивной фазе, содержание атипичных форм от 21 до 40% указывает на активизацию участка патологического процесса, содержание атипичных форм от 41 до 80% характерен для высокой степени активности локального патологического процесса с выраженной иммуносупрессией или обострением системной патологии, а наличие атипичных форм в количестве более 80% характеризует тяжелое состояние больного из системной или онкопатологией.The method of determining the activity of the pathological process in the human body by using cellular indicators of peripheral blood, counting and differentiating different forms of cells according to standard methods, the largest 200 cells in each of the samples, and determining the percentage of individual forms of cells, respectively, to specified ranges, characterized in that use Native preparations of the peripheral blood lymphocyte fraction isolated on the ficol-urographin gradient calculate the atypical percentage x erythrocytes and conduct a qualitative assessment of the quantitative indicators of the activity of the pathological condition from the calculation: the content of atypical forms of red blood cells from 6 to 20% indicates a local part of the pathological process in the inactive phase, the content of atypical forms from 21 to 40% indicates the activation of the site of the pathological process, the content of atypical forms from 41 to 80% is characteristic of a high degree of activity of the local pathological process with severe immunosuppression or exacerbation of systemic pathology, and the presence of atypical egg forms in an amount of more than 80% characterizes the serious condition of the patient from systemic or oncopathology.
RU2004120868/15A 2003-07-22 2004-07-09 METHOD FOR DETERMINING ACTIVITY OF PATHOLOGICAL PROCESS BY ASTAHOVA RU2004120868A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA2003076889A UA67125C2 (en) 2003-07-22 2003-07-22 Method for estimating the activity of pathologic process proposed by astakhova v.s.
UA2003076889 2003-07-22

Publications (1)

Publication Number Publication Date
RU2004120868A true RU2004120868A (en) 2005-12-20

Family

ID=34517662

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004120868/15A RU2004120868A (en) 2003-07-22 2004-07-09 METHOD FOR DETERMINING ACTIVITY OF PATHOLOGICAL PROCESS BY ASTAHOVA

Country Status (2)

Country Link
RU (1) RU2004120868A (en)
UA (1) UA67125C2 (en)

Also Published As

Publication number Publication date
UA67125A (en) 2004-06-15
UA67125C2 (en) 2005-05-16

Similar Documents

Publication Publication Date Title
Piccinini et al. The evaluation of non-specific immune status of heifers in field conditions during the periparturient period
Hentschke et al. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy
Ciuffetti et al. Blood rheology in men with essential hypertension and capillary rarefaction
CN106814145A (en) A kind of human-body fatigue assay method
RU2367953C1 (en) Diagnostic technique for red-cell membrane competence in peripheral blood of pregnant women suffering from herpes viral infection
Jaramillo Ortiz et al. Biomarkers of disease in human nails: A comprehensive review
Krämer et al. Influence of strenuous exercise on albumin excretion.
RU2004120868A (en) METHOD FOR DETERMINING ACTIVITY OF PATHOLOGICAL PROCESS BY ASTAHOVA
WO2003043524A3 (en) Compositions and methods for accurate early pregnancy diagnosis
Gupta et al. Role of soluble transferrin receptor and soluble transferrin receptor index in diagnosing iron deficiency anemia in patients with chronic kidney disease
Vincze et al. Assessment of equine alpha-fetoprotein levels in mares and newborn foals in the periparturient period
Hassan et al. Noninvasive fibrosis scores as prognostic markers for varices needing treatment in advanced compensated liver cirrhosis
Chen et al. Does oxygen concentration affect shedding of trophoblastic debris or production of inflammatory mediators from first trimester human placenta?
Sindhu et al. Clinico-haematobiochemical alterations and Electrocardiograhy findings in Babesia infected dogs
Unger et al. Preanalytical phase: effects of water ingestion during fasting on routine hematological parameters in a small cohort of young women
Gray et al. Serum proteins in the leopard seal, Hydrurga leptonyx, in Prydz Bay, Eastern Antarctica and the coast of NSW, Australia
Hamed et al. Evaluation of Changes in Renal Function of Pregnant Women with Preeclampsia in Al-Jabal Al-Akhdar
Odewusi et al. Urinary Protein and Creatinine Levels of Different Haptoglobin Phenotypes among a Nigerian Pre-eclamptic Population
Forsman Note on estimating catecholamines in urine sampled after 75-min periods of mental work and inactivity
CN114959013B (en) Biomarker for altitude erythrocytosis and application thereof
Edwards et al. Hemoglobins of two urodeles: changes with metamorphosis
Farrukh et al. Serum Hepcidin-25: A Predictor Of Response To Oral Iron Therapy.
RU2471194C1 (en) Diagnostic technique for erythroid cell manuration regulation in pregnancy complicated by aggravated herpes virus infection by detection of protein band 4,9 in peripheral erythrocyte membranes in third trimester of gestation
RU2004106398A (en) METHOD FOR DIAGNOSTIC OF THREATS TO ABOUT PREGNANCY
Rogers et al. A method of studying metabolic variation between individual tumors: A preliminary report

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20070810